Skip to content

Clinical trials

Completed Hyperkalemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperkalemia Status: Completed Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20092
20102
20112
20121
20131
20147
20153
20163
201710
20182
20195
20207
202111
202212
20232
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca21
ZS Pharma, Inc.7
Relypsa, Inc.6
Zeria Pharmaceutical2
Alexandria University1
Ardelyx1
Centre Hospitalier Universitaire de la Réunion1
Danderyd Hospital1
Dominic Raj1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperkalemia79
Renal Insufficiency, Chronic20
Heart Failure7
Hypertension5
Hypokalemia3
Kidney Failure, Chronic3
Acute Kidney Injury2
Diabetic Nephropathies2
Hyperphosphatemia2
Insulin Resistance2

Trials

Showing 26 to 50 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.